SCHEMBL7324040

SCHEMBL7324040

CCc1cccc(C2(O)c3ccccc3-c3ccccc32)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.51
P2RX1 P51575 1/20 0.41
P2RX3 P56373 1/20 0.41
P2RX4 Q99571 1/20 0.41
P2RX7 Q99572 1/20 0.41
HCAR3 P49019 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.38
RAF1 P04049 1/20 0.36
BRAF P15056 1/20 0.36
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322252 0.84 PDK2 (0.60) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL23996970 0.82 PDK2 (0.45) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL7321773 0.81 PDK2 (0.51) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL7312094 0.77 LMNA (0.53) PDK2ALDH1A1LMNAL3MBTL1
SCHEMBL7308746 0.74 PDK2 (0.48) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL3923017 0.74 PDK2 (0.47) PDK2
SCHEMBL7322862 0.74 PDK2 (0.50) PDK2
SCHEMBL813078 0.73 THRB (0.52) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL30345614 0.73 THRB (0.52) PDK2P2RX1P2RX3P2RX4P2RX7
SCHEMBL7315657 0.73 PDK2 (0.51) PDK2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed